- Dermatologic and Ophthalmic Drugs Advisory Committee Roster
- La FDA advierte acerca del incremento del riesgo de reincidencia del cáncer con el uso del antibiótico azitromicina (Zithromax, Zmax) a largo plazo posterior a un trasplante de células madre de donante
- FDA Adverse Event Reporting System (FAERS): Latest Quarterly Data Files
- Pediatric Exclusivity Granted
- FDA warns about increased risk of cancer relapse with long-term use of azithromycin (Zithromax, Zmax) antibiotic after donor stem cell transplant
- UPDATED INFORMATION: September 12, 2018: Meeting of the Pharmacy Compounding Advisory Committee Meeting Announcement
- Stay Informed about Small Business
- Inactive Ingredients Database Download
- Drugs@FDA Download File (new structure)
- Newly Added Guidance Documents
- Pediatric Exclusivity Statistics
- FDA Adverse Event Reporting System (FAERS) Public Dashboard
- Oncologic Drugs Advisory Committee Roster
- CDER Key Officials List
- Orange Book Patent Listing Dispute List
- Generic Drug Development
- Additions/Deletions for Prescription and OTC Drug Product Lists
- Orange Book Zip File
- Reviews of Pediatric Studies Conducted under BPCA and PREA from 2012 – present
- Potential Signals of Serious Risks/New Safety Information Identified from the FDA Adverse Event Reporting System (FAERS)
- Safe Use Initiative – Current Projects
- Medication Guides
- Drugs@FDA Data Files
- Clinical Investigator Inspection List (CLIIL)
- BMIS Zip Download File
- Presenting Risk Information in Prescription Drug and Medical Device Promotion
- Pulmonary-Allergy Drugs Advisory Committee Roster